|
1
|
EI-Naggar AK, Chan JKC, Grandis JR, Takata
T and Slootweg PJ: WHO classification of head and neck tumors. 4th
edition. IARC Press; Lyon: 2017
|
|
2
|
Diwakar JK, Agarwal A, Garg C, Giri KY,
Dandriyal R and Kumar G: A rare case of mucoepidermoid carcinoma of
parotid with mandibular metastasis. Ann Maxillofac Surg. 9:205–207.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Janet-Ofelia GC, Rafael MV, Guillermo GA,
Carlos-Enrique CV, José-Martín RM, Henry GM and Jaime-Enrique MG:
Mucoepidermoid carcinoma of the salivary glands: Survival and
prognostic factors. J Maxillofac Oral Surg. 16:431–437. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu S, Ow A, Ruan M, Yang W and Zhang C,
Wang L and Zhang C: Prognostic factors in primary salivary gland
mucoepidermoid carcinoma: An analysis of 376 cases in an Eastern
Chinese population. Int J Oral Maxillofac Surg. 43:667–673. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pusztaszeri MP and Faquin WC: Update in
salivary gland cytopathology: Recent molecular advances and
diagnostic applications. Semin Diagn Pathol. 32:264–274. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lombardi D, McGurk M, Vander Poorten V,
Guzzo M, Accorona R, Rampinelli V and Nicolai P: Surgical treatment
of salivary malignant tumors. Oral Oncol. 65:102–113. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brandwein MS, Ferlito A, Bradley PJ, Hille
JJ and Rinaldo A: Diagnosis and classification of salivary
neoplasms: Pathologic challenges and relevance to clinical
outcomes. Acta Otolaryngol. 122:758–764. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stowell SR, Ju T and Cummings RD: Protein
glycosylation in cancer. Annu Rev Pathol. 10:473–510. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Varki A: Biological roles of
oligosaccharides: All of the theories are correct. Glycobiology.
3:97–130. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Adamczyk B, Tharmalingam T and Rudd PM:
Glycans as cancer biomarkers. Biochim Biophys Acta. 1820:1347–1353.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gendler SJ: MUC1, the renaissance
molecule. J Mammary Gland Biol Neoplasia. 6:339–353. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pinto R, Carvalho AS, Conze T, Magalhães
A, Picco G, Burchell JM, Taylor-Papadimitriou J, Reis CA, Almeida
R, Mandel U, et al: Identification of new cancer biomarkers based
on aberrant mucin glycoforms by in situ proximity ligation. J Cell
Mol Med. 16:1474–1484. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Julien S, Videira PA and Delannoy P:
Sialyl-tn in cancer: (How) Did we miss the target? Biomolecules.
2:435–466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kudelka MR, Ju T, Heimburg-Molinaro J and
Cummings RD: Simple sugars to complex disease-mucin-type O-glycans
in cancer. Adv Cancer Res. 126:53–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cazet A, Julien S, Bobowski M, Burchell J
and Delannoy P: Tumour-associated carbohydrate antigens in breast
cancer. Breast Cancer Res. 12:2042010. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheever MA, Allison JP, Ferris AS, Finn
OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL,
Weiner LM and Matrisian LM: The prioritization of cancer antigens:
A national cancer institute pilot project for the acceleration of
translational research. Clin Cancer Res. 15:5323–5337. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alos L, Lujan B, Castillo M, Nadal A,
Carreras M, Caballero M, de Bolos C and Cardesa A: Expression of
membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2,
MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of
salivary glands. Am J Surg Pathol. 29:806–813. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Handra-Luca A, Lamas G, Bertrand JC and
Fouret P: MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland
mucoepidermoid carcinoma: Diagnostic and prognostic implications.
Am J Surg Pathol. 29:881–889. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsuno YK, Saito T, Gotoh M, Narimatsu H
and Kameyama A: Supported molecular matrix electrophoresis: A new
tool for characterization of glycoproteins. Anal Chem.
81:3816–3823. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kameyama A, Yamakoshi K and Watanabe A: A
rapid separation and characterization of mucins from mouse
submandibular glands by supported molecular matrix electrophoresis.
Biochim Biophys Acta Proteins Proteom. 1867:76–81. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM Classification of Malignant Tumours. 8th edition.
Wiley-Blackwell; Oxford: pp. p2722016
|
|
22
|
Yamamoto M, Bhavanandan VP, Nakamori S and
Irimura T: A novel monoclonal antibody specific for sialylated MUC1
mucin. Jpn J Cancer Res. 87:488–496. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takeuchi H, Kato K, Denda-Nagai K, Hanisch
FG, Clausen H and Irimura T: The epitope recognized by the unique
anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha
2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct
threonine residue in the MUC1 tandem repeat. J Immunol Methods.
270:199–209. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsuno YK, Dong W, Yokoyama S, Yonezawa
S, Saito T, Gotoh M, Narimatsu H and Kameyama A: Improved method
for immunostaining of mucin separated by supported molecular matrix
electrophoresis by optimizing the matrix composition and fixation
procedure. Electrophoresis. 32:1829–1836. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matsuno YK, Dong W, Yokoyama S, Yonezawa
S, Narimatsu H and Kameyama A: Identification of mucins by using a
method involving a combination of on-membrane chemical
deglycosylation and immunostaining. J Immunol Methods. 394:125–130.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu J, Sun H, Huang G, Liu G, Li Z, Yang H,
Jin L, Cui X, Shi L, Ma T, et al: A fixation method for the
optimisation of western blotting. Sci Rep. 9:66492019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ju T, Lanneau GS, Gautam T, Wang Y, Xia B,
Stowell SR, Willard MT, Wang W, Xia JY, Zuna RE, et al: Human tumor
antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer
Res. 68:1636–1646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matse JH, Bharos WK, Veerman ECI, Bloemena
E and Bolscher JGM: Mucoepidermoid carcinoma-associated expression
of MUC5AC, MUC5B and mucin-type carbohydrate antigen sialyl-Tn in
the parotid gland. Arch Oral Biol. 82:121–126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pushpass RG, Pellicciotta N, Kelly C,
Proctor G and Carpenter GH: Reduced salivary mucin binding and
glycosylation in older adults influences taste in an in vitro cell
model. Nutrients. 11:22802019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bafna S, Kaur S and Batra SK:
Membrane-bound mucins: The mechanistic basis for alterations in the
growth and survival of cancer cells. Oncogene. 29:2893–2904. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu F, Liu F, Zhao H, An G and Feng G:
Prognostic significance of mucin antigen MUC1 in various human
epithelial cancers: A meta-analysis. Medicine (Baltimore).
94:e22862015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peraza A, Gómez R, Beltran J and Amarista
FJ: Mucoepidermoid carcinoma. An update and review of the
literature. J Stomatol Oral Maxillofac Surg. 121:713–720. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sengupta A, Valdramidou D, Huntley S,
Hicks SJ, Carrington SD and Corfield AP: Distribution of MUC1 in
the normal human oral cavity is localized to the ducts of minor
salivary glands. Arch Oral Biol. 46:529–538. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ponce-Bravo S, Ledesma-Montes C and
Morales-Sánchez I: MUC-1 mucin in normal human salivary glands
detected by HMFG-1 and HMFG-2 monoclonal antibodies. APMIS.
116:93–98. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Levitin F, Stern O, Weiss M, Gil-Henn C,
Ziv R, Prokocimer Z, Smorodinsky NI, Rubinstein DB and Wreschner
DH: The MUC1 SEA module is a self-cleaving domain. J Biol Chem.
280:33374–33386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Duraisamy S, Kufe T, Ramasamy S and Kufe
D: Evolution of the human MUC1 oncoprotein. Int J Oncol.
31:671–677. 2007.PubMed/NCBI
|
|
37
|
Ma S, An F, Li LH, Lin YY and Wang J:
Expression of Mucin 1 in salivary gland tumors and its correlation
with clinicopathological factors. J Biol Regul Homeost Agents.
33:563–569. 2019.PubMed/NCBI
|
|
38
|
Kusafuka K, Itoh H, Sugiyama C and
Nakajima T: Low-grade salivary duct carcinoma of the parotid gland:
Report of a case with immunohistochemical analysis. Med Mol
Morphol. 43:178–184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cros J, Sbidian E, Hans S, Roussel H,
Scotte F, Tartour E, Brasnu D, Laurent-Puig P, Bruneval P, Blons H
and Badoual C: Expression and mutational status of
treatment-relevant targets and key oncogenes in 123 malignant
salivary gland tumours. Ann Oncol. 24:2624–2629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Khurram SA, Sultan-Khan J, Atkey N and
Speight PM: Cytogenetic and immunohistochemical characterization of
mammary analogue secretory carcinoma of salivary glands. Oral Surg
Oral Med Oral Pathol Oral Radiol. 122:731–742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
St Hill CA, Farooqui M, Mitcheltree G,
Gulbahce HE, Jessurun J, Cao Q and Walcheck B: The high affinity
selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2
beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly
expressed in human colorectal adenocarcinomas. BMC Cancer.
9:792009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Machida E, Nakayama J, Amano J and Fukuda
M: Clinicopathological significance of core 2
beta1,6-N-acetylglucosaminyltransferase messenger RNA expressed in
the pulmonary adenocarcinoma determined by in situ hybridization.
Cancer Res. 61:2226–2231. 2001.PubMed/NCBI
|
|
43
|
Chen Z, Gulzar ZG, St Hill CA, Walcheck B
and Brooks JD: Increased expression of GCNT1 is associated with
altered O-glycosylation of PSA, PAP, and MUC1 in human prostate
cancers. Prostate. 74:1059–1067. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tsuboi S, Sutoh M, Hatakeyama S, Hiraoka
N, Habuchi T, Horikawa Y, Hashimoto Y, Yoneyama T, Mori K, Koie T,
et al: A novel strategy for evasion of NK cell immunity by tumours
expressing core2 O-glycans. EMBO J. 30:3173–3185. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Basu S, Basu M and Basu SS: Biological
specificity of sialyltransferases. Biology of the sialic acids.
Rosenberg A: Plenum Press; New York: pp. 69–94. 1995, View Article : Google Scholar
|
|
46
|
Vajaria BN, Patel KR, Begum R and Patel
PS: Sialylation: An avenue to target cancer cells. Pathol Oncol
Res. 22:443–447. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kirwan A, Utratna M, O'Dwyer ME, Joshi L
and Kilcoyne M: Glycosylation-based serum biomarkers for cancer
diagnostics and prognostics. Biomed Res Int. 2015:4905312015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li X, Xu Y and Zhang L: Serum CA153 as
biomarker for cancer and noncancer diseases. Prog Mol Biol Transl
Sci. 162:265–276. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ishikawa N, Hattori N, Yokoyama A and
Kohno N: Utility of KL-6/MUC1 in the clinical management of
interstitial lung diseases. Respir Investig. 50:3–13. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Silsirivanit A, Matsuda A, Kuno A, Tsuruno
C, Uenoyama Y, Seubwai W, Angata K, Teeravirote K, Wongkham C,
Araki N, et al: Multi-serum glycobiomarkers improves the diagnosis
and prognostic prediction of cholangiocarcinoma. Clin Chim Acta.
510:142–149. 2020. View Article : Google Scholar : PubMed/NCBI
|
